nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Alkylating Activity—Carmustine—malignant glioma	0.591	1	CiPCiCtD
Temozolomide—brain cancer—malignant glioma	0.385	1	CtDrD
Temozolomide—Edema cerebral—Carmustine—malignant glioma	0.00192	0.0833	CcSEcCtD
Temozolomide—Infertility—Carmustine—malignant glioma	0.00114	0.0493	CcSEcCtD
Temozolomide—Acute leukaemia—Carmustine—malignant glioma	0.00104	0.0451	CcSEcCtD
Temozolomide—Brain oedema—Carmustine—malignant glioma	0.00104	0.0451	CcSEcCtD
Temozolomide—Hemiplegia—Carmustine—malignant glioma	0.000832	0.0361	CcSEcCtD
Temozolomide—Pulmonary fibrosis—Carmustine—malignant glioma	0.000675	0.0293	CcSEcCtD
Temozolomide—Myelosuppression—Carmustine—malignant glioma	0.000633	0.0275	CcSEcCtD
Temozolomide—Faecal incontinence—Carmustine—malignant glioma	0.000589	0.0255	CcSEcCtD
Temozolomide—Cerebral haemorrhage—Carmustine—malignant glioma	0.000537	0.0233	CcSEcCtD
Temozolomide—Febrile neutropenia—Carmustine—malignant glioma	0.000494	0.0214	CcSEcCtD
Temozolomide—Oral candidiasis—Carmustine—malignant glioma	0.000468	0.0203	CcSEcCtD
Temozolomide—Aphasia—Carmustine—malignant glioma	0.000458	0.0199	CcSEcCtD
Temozolomide—Interstitial lung disease—Carmustine—malignant glioma	0.00042	0.0182	CcSEcCtD
Temozolomide—Scotoma—Carmustine—malignant glioma	0.000391	0.017	CcSEcCtD
Temozolomide—Hepatotoxicity—Carmustine—malignant glioma	0.000385	0.0167	CcSEcCtD
Temozolomide—Speech disorder—Carmustine—malignant glioma	0.000345	0.015	CcSEcCtD
Temozolomide—Gait disturbance—Carmustine—malignant glioma	0.000304	0.0132	CcSEcCtD
Temozolomide—Coordination abnormal—Carmustine—malignant glioma	0.000302	0.0131	CcSEcCtD
Temozolomide—Pulmonary embolism—Carmustine—malignant glioma	0.000297	0.0129	CcSEcCtD
Temozolomide—Urinary incontinence—Carmustine—malignant glioma	0.000287	0.0124	CcSEcCtD
Temozolomide—Depressed level of consciousness—Carmustine—malignant glioma	0.000287	0.0124	CcSEcCtD
Temozolomide—Candida infection—Carmustine—malignant glioma	0.000284	0.0123	CcSEcCtD
Temozolomide—Skin exfoliation—Carmustine—malignant glioma	0.000284	0.0123	CcSEcCtD
Temozolomide—Neuropathy—Carmustine—malignant glioma	0.000279	0.0121	CcSEcCtD
Temozolomide—Neoplasm—Carmustine—malignant glioma	0.000269	0.0116	CcSEcCtD
Temozolomide—Abnormal vision—Carmustine—malignant glioma	0.000259	0.0112	CcSEcCtD
Temozolomide—Mental disability—Carmustine—malignant glioma	0.000258	0.0112	CcSEcCtD
Temozolomide—Thrombophlebitis—Carmustine—malignant glioma	0.000249	0.0108	CcSEcCtD
Temozolomide—Eye pain—Carmustine—malignant glioma	0.000239	0.0104	CcSEcCtD
Temozolomide—Amnesia—Carmustine—malignant glioma	0.00023	0.00995	CcSEcCtD
Temozolomide—Diplopia—Carmustine—malignant glioma	0.000216	0.00935	CcSEcCtD
Temozolomide—Face oedema—Carmustine—malignant glioma	0.000208	0.00903	CcSEcCtD
Temozolomide—Ataxia—Carmustine—malignant glioma	0.000203	0.00879	CcSEcCtD
Temozolomide—Hypokalaemia—Carmustine—malignant glioma	0.000196	0.00851	CcSEcCtD
Temozolomide—Muscular weakness—Carmustine—malignant glioma	0.00019	0.00825	CcSEcCtD
Temozolomide—Dysphagia—Carmustine—malignant glioma	0.000186	0.00808	CcSEcCtD
Temozolomide—Pancytopenia—Carmustine—malignant glioma	0.000177	0.00767	CcSEcCtD
Temozolomide—Neutropenia—Carmustine—malignant glioma	0.000174	0.00756	CcSEcCtD
Temozolomide—Hyperglycaemia—Carmustine—malignant glioma	0.000168	0.00729	CcSEcCtD
Temozolomide—Pneumonia—Carmustine—malignant glioma	0.000167	0.00725	CcSEcCtD
Temozolomide—Depression—Carmustine—malignant glioma	0.000166	0.00718	CcSEcCtD
Temozolomide—Neuropathy peripheral—Carmustine—malignant glioma	0.000163	0.00706	CcSEcCtD
Temozolomide—Stomatitis—Carmustine—malignant glioma	0.000162	0.00702	CcSEcCtD
Temozolomide—Urinary tract infection—Carmustine—malignant glioma	0.000162	0.007	CcSEcCtD
Temozolomide—Haemoglobin—Carmustine—malignant glioma	0.00015	0.0065	CcSEcCtD
Temozolomide—Haemorrhage—Carmustine—malignant glioma	0.000149	0.00647	CcSEcCtD
Temozolomide—Hallucination—Carmustine—malignant glioma	0.000148	0.00644	CcSEcCtD
Temozolomide—Hypoaesthesia—Carmustine—malignant glioma	0.000148	0.00644	CcSEcCtD
Temozolomide—Oedema peripheral—Carmustine—malignant glioma	0.000147	0.00637	CcSEcCtD
Temozolomide—Connective tissue disorder—Carmustine—malignant glioma	0.000147	0.00636	CcSEcCtD
Temozolomide—Visual impairment—Carmustine—malignant glioma	0.000144	0.00623	CcSEcCtD
Temozolomide—Eye disorder—Carmustine—malignant glioma	0.000139	0.00604	CcSEcCtD
Temozolomide—Flushing—Carmustine—malignant glioma	0.000138	0.006	CcSEcCtD
Temozolomide—Alopecia—Carmustine—malignant glioma	0.000132	0.00572	CcSEcCtD
Temozolomide—Mental disorder—Carmustine—malignant glioma	0.000131	0.00567	CcSEcCtD
Temozolomide—Erythema—Carmustine—malignant glioma	0.00013	0.00563	CcSEcCtD
Temozolomide—Malnutrition—Carmustine—malignant glioma	0.00013	0.00563	CcSEcCtD
Temozolomide—Back pain—Carmustine—malignant glioma	0.000126	0.00545	CcSEcCtD
Temozolomide—Vision blurred—Carmustine—malignant glioma	0.000122	0.00531	CcSEcCtD
Temozolomide—Tremor—Carmustine—malignant glioma	0.000122	0.00527	CcSEcCtD
Temozolomide—Anaemia—Carmustine—malignant glioma	0.00012	0.0052	CcSEcCtD
Temozolomide—Agitation—Carmustine—malignant glioma	0.000119	0.00517	CcSEcCtD
Temozolomide—Leukopenia—Carmustine—malignant glioma	0.000116	0.00504	CcSEcCtD
Temozolomide—Convulsion—Carmustine—malignant glioma	0.000113	0.00488	CcSEcCtD
Temozolomide—Hypertension—Carmustine—malignant glioma	0.000112	0.00486	CcSEcCtD
Temozolomide—Myalgia—Carmustine—malignant glioma	0.000111	0.00479	CcSEcCtD
Temozolomide—Anxiety—Carmustine—malignant glioma	0.00011	0.00478	CcSEcCtD
Temozolomide—Confusional state—Carmustine—malignant glioma	0.000107	0.00463	CcSEcCtD
Temozolomide—Oedema—Carmustine—malignant glioma	0.000106	0.00459	CcSEcCtD
Temozolomide—Infection—Carmustine—malignant glioma	0.000105	0.00456	CcSEcCtD
Temozolomide—Thrombocytopenia—Carmustine—malignant glioma	0.000104	0.0045	CcSEcCtD
Temozolomide—Anorexia—Carmustine—malignant glioma	0.000101	0.00438	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Carmustine—malignant glioma	9.66e-05	0.00419	CcSEcCtD
Temozolomide—Insomnia—Carmustine—malignant glioma	9.59e-05	0.00416	CcSEcCtD
Temozolomide—Paraesthesia—Carmustine—malignant glioma	9.52e-05	0.00413	CcSEcCtD
Temozolomide—Dyspnoea—Carmustine—malignant glioma	9.45e-05	0.0041	CcSEcCtD
Temozolomide—Somnolence—Carmustine—malignant glioma	9.42e-05	0.00408	CcSEcCtD
Temozolomide—Decreased appetite—Carmustine—malignant glioma	9.21e-05	0.00399	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Carmustine—malignant glioma	9.15e-05	0.00397	CcSEcCtD
Temozolomide—Constipation—Carmustine—malignant glioma	9.06e-05	0.00393	CcSEcCtD
Temozolomide—Pain—Carmustine—malignant glioma	9.06e-05	0.00393	CcSEcCtD
Temozolomide—Feeling abnormal—Carmustine—malignant glioma	8.73e-05	0.00379	CcSEcCtD
Temozolomide—Gastrointestinal pain—Carmustine—malignant glioma	8.67e-05	0.00376	CcSEcCtD
Temozolomide—Body temperature increased—Carmustine—malignant glioma	8.38e-05	0.00363	CcSEcCtD
Temozolomide—Abdominal pain—Carmustine—malignant glioma	8.38e-05	0.00363	CcSEcCtD
Temozolomide—Hypersensitivity—Carmustine—malignant glioma	7.81e-05	0.00339	CcSEcCtD
Temozolomide—Asthenia—Carmustine—malignant glioma	7.6e-05	0.0033	CcSEcCtD
Temozolomide—Diarrhoea—Carmustine—malignant glioma	7.25e-05	0.00314	CcSEcCtD
Temozolomide—Dizziness—Carmustine—malignant glioma	7.01e-05	0.00304	CcSEcCtD
Temozolomide—Vomiting—Carmustine—malignant glioma	6.74e-05	0.00292	CcSEcCtD
Temozolomide—Rash—Carmustine—malignant glioma	6.68e-05	0.0029	CcSEcCtD
Temozolomide—Dermatitis—Carmustine—malignant glioma	6.68e-05	0.00289	CcSEcCtD
Temozolomide—Headache—Carmustine—malignant glioma	6.64e-05	0.00288	CcSEcCtD
Temozolomide—Nausea—Carmustine—malignant glioma	6.3e-05	0.00273	CcSEcCtD
